Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1996;27:2040-2042

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujikawa, T.
Right arrow Articles by Yamawaki, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujikawa, T.
Right arrow Articles by Yamawaki, S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Antidepressants

(Stroke. 1996;27:2040-2042.)
© 1996 American Heart Association, Inc.


Articles

Response of Patients With Major Depression and Silent Cerebral Infarction to Antidepressant Drug Therapy, With Emphasis on Central Nervous System Adverse Reactions

Tokumi Fujikawa, MD, PhD; Norio Yokota, MD, PhD; Mitsutaro Muraoka, MD Shigeto Yamawaki, MD, PhD

the Department of Psychiatry and Neurosciences (T.F., N.Y., M.M., S.Y.), Hiroshima University School of Medicine, and Department of Psychiatry (T.F.), National Sanatorium Kamo Hospital, Hiroshima, Japan.

Correspondence to T. Fujikawa, MD, PhD, Department of Psychiatry, National Sanatorium Kamo Hospital, 92 Minamigata, Kurose-cho, Kamo-gun, Hiroshima 724-06, Japan.

Background and Purpose We previously found that silent cerebral infarction (SCI) is present in most patients older than 50 years with major depression. The present study was designed to clarify the response to antidepressant pharmacotherapy in patients with major depression associated with SCI.

Methods Using clinical charts, we retrospectively studied patients older than 50 years who were admitted for antidepressant drug therapy. Patients with bipolar affective disorder and those with focal neurological symptoms were excluded. All patients underwent magnetic resonance imaging and were classified as SCI-negative or SCI-positive. The SCI-positive group was subclassified into those with moderate SCI (either perforating area or cortical area) (n=15) and those with severe SCI (both perforating and cortical areas) (n=7). Duration of treatment in hospital and the incidence of central nervous system adverse reactions to the antidepressant drugs were compared between the two groups.

Results The duration of hospital treatment in patients with severe SCI was significantly longer than in those with moderate SCI (P<.01). The percentage of patients with adverse central nervous system reactions to antidepressant drugs was significantly higher in the SCI-positive group than in the SCI-negative group (P<.05). Patients with severe SCI had significantly more adverse reactions than those with moderate SCI (P<.05).

Conclusions Depressed patients with severe SCI required longer hospital treatment and had more drug-related adverse reactions of the central nervous system. These findings suggest that the depression associated with severe SCI may be resistant to treatment.


Key Words: antidepressive agents • central nervous system • cerebral infarction • depression • magnetic resonance imaging




This article has been cited by other articles:


Home page
RadiologyHome page
S. Lui, L. M. Parkes, X. Huang, K. Zou, R. C. K. Chan, H. Yang, L. Zou, D. Li, H. Tang, T. Zhang, et al.
Depressive Disorders: Focally Altered Cerebral Perfusion Measured with Arterial Spin-labeling MR Imaging
Radiology, May 1, 2009; 251(2): 476 - 484.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. Salzman
A 60-Year-Old Woman Who Has Felt Sad for Much of Her Life
JAMA, January 18, 2006; 295(3): 318 - 323.
[Full Text] [PDF]


Home page
StrokeHome page
D. C. Steffens, K. R. R. Krishnan, C. Crump, and G. L. Burke
Cerebrovascular Disease and Evolution of Depressive Symptoms in the Cardiovascular Health Study
Stroke, June 1, 2002; 33(6): 1636 - 1644.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
J. J. Campbell III and C. E. Coffey
Neuropsychiatric Significance of Subcortical Hyperintensity
J Neuropsychiatry Clin Neurosci, May 1, 2001; 13(2): 261 - 288.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C. Ugur, D. Gucuyener, N. Uzuner, S. Ozkan, and G. Ozdemir
Characteristics of falling in patients with stroke
J. Neurol. Neurosurg. Psychiatry, November 1, 2000; 69(5): 649 - 651.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. Matsuo, T. Kato, M. Fukuda, and N. Kato
Alteration of Hemoglobin Oxygenation in the Frontal Region in Elderly Depressed Patients as Measured by Near-infrared Spectroscopy
J Neuropsychiatry Clin Neurosci, November 1, 2000; 12(4): 465 - 471.
[Abstract] [Full Text]


Home page
StrokeHome page
T. Fujikawa, I. Yanai, and S. Yamawaki
Psychosocial Stressors in Patients With Major Depression and Silent Cerebral Infarction
Stroke, June 1, 1997; 28(6): 1123 - 1125.
[Abstract] [Full Text]